Regulus proposes follow-on

Regulus Therapeutics Inc. (NASDAQ:RGLS), San Diego, Calif. Business: Infectious, Cancer, Cardiovascular Date announced: 6/26/13 Type: Follow-on To be raised: TBD Shares: TBD Price prior: $9.20 Underwr...